Life Sciences Practice
IT/Telco Practice
Megatrends Analysis
Market Research
Methods

   

Life Science Practice

Pharmaceuticals, biotechnology, medical devices, diagnostics, genomics, CRO and managed care companies have relied on our primary intelligence services since 1992 – on average for 10-12  years. Our MD- and PhD-level CI analysts specialize in the following 13 therapeutic areas:

  1. Cardiology – Hypertension, AMI, CRF, thrombosis, heart failure, angina, anticoagulants, atherosclerosis, deep vein thrombosis (DVT), stroke, peripheral arterial disease (PAD), etc.
  2. Oncology – NHL, hematology, solid tumors: breast cancer, CRC, NSCLC, prostate, GI, liver, pancreatic, RCC, etc.
  3. Pain Management – neuropathic pain, opioids, buprenorphin patches, topical analgesia, etc.
  4. Neurology – Multiple sclerosis (MS), Major depressive disorders (MDD), general anxiety disorders (GAD), Alzheimer’s disease (AD), bipolar disorders, Parkinson’s disease (PD), insomnia, etc.
  5. Diabetes/Metabolism – GLP-1s, DPP-4s & SGLT-2s drug classes, dyslipidemia, obesity, metabolic myopathies, etc.
  6. Endocrinology
  7. Autoimmune Diseases & Transplantation – Rheumatoid arthritis (RA), psoriasis, Crohn’s disease, IBD, lupus, acute dermatitis, allergic rhinitis, etc.
  8. Women’s Health
  9. Vaccines
  10. Respiratory – asthma, COPD, allergy, cystic fibrosis (CF), pulmonary arterial hypertension (PAH), allergic rhinitis and allergic asthma, etc.
  11. Infectious Diseases – hepatitis C & B, AIDS, HIV, influenza, MRSA, chronic liver/renal disease, etc.
  12. Musculoskeletal Diseases – osteoporosis, osteoarthritis, sarcopenia, etc.
  13. Gastroenterology – Dyspepsia, peptic ulcer, ulcerative colitis, Crohn’s disease, and GORD

Core Service Offerings to Life Sciences Companies:

  1. Continuous systematic competitor tracking
  2. (Pre)clinical & commercial deep dives and tracking
  3. Fast turnaround CI ad hoc inquiries – “CI Hotline” to provide rapid responses & guidance
  4. Generics and biosimilars threat assessments
  5. Rotating KOL and MCO (pharmacy and medical director) panels
  6. Competitive benchmarking – “best practices”
  7. Competitive landscape assessments
  8. KOL/physician/MCO perceptions monitoring
  9. Strategic market opportunity assessments
  10. Conference & symposia coverage/booth intelligence
  11. Data leakage assessments & counter-intelligence programs
 
 

EAST COAST | MIAMI, FL
PH 1.305.913.1350

info@isisglobal.com
WEST COAST | PALO ALTO, CA
PH 1.650.298.8555

info@isisglobal.com
EUROPE | LUCERNE
PH 41.41.455.2522

info@isisglobal.com
ASIA | SHANGHAI
PH 86.21.6103.7308

info@isisglobal.com